Citigroup’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,000
Closed -$5.93M 6002
2025
Q4
$5.93M Buy
+75,000
New +$5.88M ﹤0.01% 1898
2025
Q1
Sell
-420,000
Closed -$38.2M 5635
2024
Q4
$38.2M Sell
420,000
-100,000
-19% -$9.54M 0.02% 630
2024
Q3
$54M Hold
520,000
0.03% 491
2024
Q2
$50.5M Hold
520,000
0.03% 492
2024
Q1
$46.8M Buy
520,000
+58,000
+13% +$4.91M 0.03% 515
2023
Q4
$36.8M Sell
462,000
-250,000
-35% -$18.8M 0.03% 576
2023
Q3
$50.6M Hold
712,000
0.04% 424
2023
Q2
$54.9M Buy
712,000
+500,000
+236% +$38.7M 0.04% 405
2023
Q1
$15.9M Buy
+212,000
New +$15.8M 0.01% 926
2022
Q2
Sell
-340,000
Closed -$25.8M 6278
2022
Q1
$25.8M Buy
340,000
+60,000
+21% +$4.75M 0.02% 812
2021
Q4
$23.9M Buy
280,000
+250,000
+833% +$19.5M 0.01% 906
2021
Q3
$2.27M Hold
30,000
﹤0.01% 2443
2021
Q2
$2.44M Sell
30,000
-10,000
-25% -$818K ﹤0.01% 2516
2021
Q1
$3.15M Sell
40,000
-87,200
-69% -$6.83M ﹤0.01% 2163
2020
Q4
$10.9M Buy
127,200
+25,900
+26% +$2.14M 0.01% 1489
2020
Q3
$7.82M Sell
101,300
-64,100
-39% -$4.89M 0.01% 1561
2020
Q2
$12.1M Buy
165,400
+23,800
+17% +$1.69M 0.01% 1165
2020
Q1
$9.4M Sell
141,600
-176,800
-56% -$12.5M 0.01% 1204
2019
Q4
$21.9M Buy
318,400
+8,000
+3% +$545K 0.02% 914
2019
Q3
$22.8M Buy
310,400
+209,200
+207% +$15.2M 0.02% 837
2019
Q2
$7.25M Buy
101,200
+22,500
+29% +$1.6M 0.01% 1646
2019
Q1
$5.39M Sell
78,700
-226,300
-74% -$14.6M 0.01% 1719
2018
Q4
$18.2M Buy
305,000
+65,200
+27% +$4.08M 0.02% 888
2018
Q3
$16.1M Buy
239,800
+47,900
+25% +$3.19M 0.01% 980
2018
Q2
$12.4M Buy
191,900
+45,400
+31% +$2.97M 0.01% 1120
2018
Q1
$10.5M Sell
146,500
-38,400
-21% -$2.76M 0.01% 1198
2017
Q4
$14M Buy
184,900
+46,400
+34% +$3.39M 0.01% 1060
2017
Q3
$10.1M Sell
138,500
-43,800
-24% -$3.16M 0.01% 1229
2017
Q2
$13.5M Sell
182,300
-4,500
-2% -$334K 0.01% 954
2017
Q1
$13.7M Buy
186,800
+30,600
+20% +$2.14M 0.01% 930
2016
Q4
$10.2M Buy
156,200
+8,500
+6% +$583K 0.01% 1178
2016
Q3
$11M Sell
147,700
-102,200
-41% -$7.56M 0.01% 1018
2016
Q2
$18.3M Buy
249,900
+12,700
+5% +$904K 0.02% 686
2016
Q1
$16.8M Sell
237,200
-173,200
-42% -$11.5M 0.02% 690
2015
Q4
$27.3M Buy
410,400
+5,200
+1% +$346K 0.03% 600
2015
Q3
$25.7M Sell
405,200
-151,800
-27% -$9.92M 0.02% 600
2015
Q2
$36.4M Buy
557,000
+183,000
+49% +$12.4M 0.03% 496
2015
Q1
$25.9M Buy
374,000
+105,300
+39% +$7.28M 0.03% 637
2014
Q4
$18.6M Sell
268,700
-27,400
-9% -$1.85M 0.02% 857
2014
Q3
$19.3M Buy
296,100
+93,400
+46% +$6.16M 0.02% 829
2014
Q2
$13.8M Sell
202,700
-208,900
-51% -$14M 0.01% 1035
2014
Q1
$26.7M Buy
411,600
+236,600
+135% +$14.9M 0.03% 573
2013
Q4
$11.4M Sell
175,000
-265,600
-60% -$17M 0.01% 1144
2013
Q3
$26.1M Sell
440,600
-39,500
-8% -$2.34M 0.02% 603
2013
Q2
$27.5M Buy
+480,100
New +$28.5M 0.03% 537

Other funds holding CL

Citigroup's CL Position: Q1 2026 in Review

Citigroup increased its Colgate-Palmolive (CL) stake by 51% in Q1 2026, buying an estimated $37M and bringing the position to 1,227,068 shares worth $105M. The position accounts for 0.04% of the portfolio, ranked #392.

Citigroup first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $167M in Q4 2019. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Citigroup held 1,227,068 shares of Colgate-Palmolive worth $105M as of Q1 2026.
  • Citigroup bought 414,652 Colgate-Palmolive shares in Q1 2026, an estimated $37M.
  • Colgate-Palmolive made up 0.04% of Citigroup's portfolio in Q1 2026, its #392 holding.
  • Citigroup first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Colgate-Palmolive position peaked at $167M in Q4 2019.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.